Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
Quick facts
Marketed products
- Amoxicilli · Infectious Disease
Phase 3 pipeline
- LXI-15028 · Diabetes
LXI-15028 is a small molecule drug that targets the SGLT2 receptor.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. portfolio CI brief
- Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. pipeline updates RSS
Frequently asked questions about Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
What are Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.'s marketed drugs?
Top marketed products include Amoxicilli.
What is Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.'s pipeline?
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. has 1 drugs in Phase 3, 0 in Phase 2, 5 in Phase 1. Late-stage candidates include LXI-15028.
Related
- Amoxicilli · Infectious Disease
- Sector hub: All tracked pharma companies